Thioflavin derivatives and their use in diagnosis and therapy of Alzheimer's disease
Details for Australian Patent Application No. 2008202626 (hide)
International Classifications
Event Publications
3 July 2008 Application Open to Public Inspection
Published as AU-B-2008202626
3 July 2008 Complete Application Filed
24 September 2009 Amendment Made
The nature of the amendment is: Amend the applicant name to University of Pittsburgh - of the Commonwealth System of Higher Education
4 February 2010 Application Accepted
Published as AU-B-2008202626
3 June 2010 Standard Patent Sealed
23 June 2011 Licence Registered
University of Pittsburgh - of the Commonwealth System of Higher Education ( GE Healthcare Limited ) Mortgages Registered - Section 187, Reg. 19 (The name in the parentheses is that of the mortgagee)
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser